Key result
Porcine submucosa mitral valves demonstrate robust extracellular matrix formation and native tissue integration in baboons.
Why the study?
The study investigated the in vivo tissue remodeling responses following implantation of a bioscaffold mitral valve consisting of porcine small intestinal submucosa in a juvenile non-human primate model.
Does bioscaffold mitral valve replacement using PSIS promote in vivo tissue remodeling and ECM formation in a juvenile baboon model?
Does bioscaffold mitral valve replacement using PSIS promote in vivo tissue remodeling and ECM formation in a juvenile baboon model?
Bioscaffold mitral valves made of porcine small intestinal submucosa demonstrate robust de novo extracellular matrix formation and integration with native tissue in a juvenile non-human primate model up to 20 months post-implant.
Supports bioscaffold valve development in large-animal models; leaves open durability and human translation.
The utility of implanting a bioscaffold mitral valve consisting of porcine small intestinal submucosa (PSIS) in a juvenile baboon model (12 to 14 months old at the time of implant; n = 3) to assess their in vivo tissue remodeling responses was investigated. Our findings demonstrated that the PSIS mitral valve exhibited the robust presence of de novo extracellular matrix (ECM) at all explantation time points (at 3-, 11-, and 20-months). Apart from a significantly lower level of proteoglycans in the implanted valve’s annulus region (p < 0.05) at 3 months compared to the 11- and 20-month explants, there were no other significant differences (p > 0.05) found between any of the other principal valve ECM components (collagen and elastin) at the leaflet, annulus, or chordae tendinea locations, across these time points. In particular, neochordae tissue had formed, which seamlessly integrated with the native papillary muscles. However, additional processing will be required to trigger accelerated, uniform and complete valve ECM formation in the recipient. Regardless of the specific processing done to the bioscaffold valve, in this proof-of-concept study, we estimate that a 3-month window following bioscaffold valve replacement is the timeline in which complete regeneration of the valve and integration with the host needs to occur.
No takes yet. Share an insight, caveat, or question.
Gonzalez et al. (2021) studied Mitral valve replacement (preclinical model) (n=3). Porcine small intestinal submucosa (PSIS) bioscaffold mitral valve vs. Native mitral valve was evaluated on Extracellular matrix (ECM) components (collagen, elastin, proteoglycans) at leaflet, annulus, or chordae tendinea. Implantation of a porcine small intestinal submucosa mitral valve in a juvenile baboon model demonstrated robust de novo extracellular matrix formation across 3 to 20 months, with neochordae tissue integrating with native papillary muscles.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: